Cap2tm1c(EUCOMM)Wtsi
Targeted Allele Detail
|
Symbol: |
Cap2tm1c(EUCOMM)Wtsi |
Name: |
cyclase associated actin cytoskeleton regulatory protein 2; targeted mutation 1c, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:5806472 |
Synonyms: |
cap2loxp |
Gene: |
Cap2 Location: Chr13:46655379-46803757 bp, + strand Genetic Position: Chr13, 23.83 cM
|
Alliance: |
Cap2tm1c(EUCOMM)Wtsi page
|
IMPC: |
Cap2 gene page |
|
Mutant Cell Lines: |
EPD0155_4_C08, EPD0155_4_E05 |
Germline Transmission: |
Earliest citation of germline transmission:
J:234044
|
Parent Cell Line: |
JM8.N4 (ES Cell)
|
Strain of Origin: |
C57BL/6N
|
Project Collection: |
EUCOMM
|
|
Allele Type: |
|
Targeted (Conditional ready, No functional change) |
Mutation: |
|
Insertion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 46684001 of Chromosome 13 upstream of exon 3 (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of exon 3 at position 46684843. Exon 3 thus flanked by loxP sites. A "conditional ready" (floxed) allele was created by flp recombinase expression in mice, deleting the lacZ sequences and neomycin seletion cassette and leaving exon 3 flanked by loxP sites. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml.
(J:234044)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
Original: |
J:234044 Field J, et al., CAP2 in cardiac conduction, sudden cardiac death and eye development. Sci Rep. 2015;5:17256 |
All: |
1 reference(s) |
|